55-73-2
Chemical Structure
Bethanidine
Synonym(s): BW 467C60 free base
- CAS No.: 55-73-2
- Formula:C10H15N3
- Molecular Weight:177.25
IUPAC Name: 2-benzyl-1,3-dimethylguanidine
InChIKey: NIVZHWNOUVJHKV-UHFFFAOYSA-N
SMILES: N(=C(NC)NC)CC=1C=CC=CC1
Biological Activity: Bethanidine (BW 467C60 (free base)) is an orally active antihypertensive agent and adrenergic neuron blocking agent. Bethanidine exerts its antihypertensive effect by inhibiting the release of norepinephrine from sympathetic nerve terminals. Bethanidine prolongs the action potential duration and the effective/functional refractory period, slows the recovery of membrane excitability after repolarization, and suppresses spontaneous action potentials induced by paired stimulation when the refractory period is sufficiently prolonged. Bethanidine shortens the duration of ventricular tachyarrhythmias and prevents electrically induced ventricular tachycardia. Bethanidine reduces metabolic rate and improves energy utilization efficiency in mice, resulting in a significant increase in body fat. Bethanidine restores tyramine-induced cardiovascular effects in Reserpine (HY-N0480)-treated anesthetized rats depleted of catecholamines. Bethanidine can be used in research on arrhythmias, inflammatory bowel disease, and primary hypertension[1][2][3][4][5].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bethanidine | Bethanidine (BW 467C60 (free base)) is an orally active antihypertensive agent and adrenergic neuron blocking agent. Bethanidine exerts its antihypertensive effect by inhibiting the release of norepinephrine from sympathetic nerve terminals. Bethanidine prolongs the action potential duration and the effective/functional refractory period, slows the recovery of membrane excitability after repolarization, and suppresses spontaneous action potentials induced by paired stimulation when the refractory period is sufficiently prolonged. Bethanidine shortens the duration of ventricular tachyarrhythmias and prevents electrically induced ventricular tachycardia. Bethanidine reduces metabolic rate and improves energy utilization efficiency in mice, resulting in a significant increase in body fat. Bethanidine restores tyramine-induced cardiovascular effects in Reserpine (HY-N0480)-treated anesthetized rats depleted of catecholamines. Bethanidine can be used in research on arrhythmias, inflammatory bowel disease, and primary hypertension. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Northover BJ, et al. A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro. British journal of pharmacology. 1985 Mar;84(3):755-63.
- [2]. Wu J, et al. Miniature rose alleviates inflammatory bowel disease in mice by modulating gut microbiota, inhibiting TLR4, enhancing tight junction proteins, and promoting metabolism. Frontiers in Microbiology. 2025;16:1721294.
- [3]. Lin M, et al. Emerging role of SENP1 in tumorigenesis and cancer therapy. Frontiers in Pharmacology. 2024 Feb 8;15:1354323. [Content Brief]
- [4]. Clarke DE. Restoration of tyramine responses by bretylium, et al. British Journal of Pharmacology. 1970 Jan;38(1):1.
- [5]. Dulloo AG, et al. Increased body fat due to elevated energetic efficiency following chronic administration of inhibitors of sympathetic nervous system activity. Metabolism: clinical and experimental. 1985 Nov;34(11):1061-5.